Polymer heart valve study for mitral valve disease
Part of Heart & circulation clinical trials.
This trial is testing a new polymer artificial heart valve for people with severe mitral valve problems. It aims to see if this valve is safe and works well during surgical replacement.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 60 years or older.
- You must have severe mitral regurgitation or severe mitral stenosis confirmed by an echocardiogram.
- You must be scheduled to have your mitral valve replaced surgically.
- Your heart's pumping ability must be at least 50% (LVEF ≥ 50%).
- You should not have had heart surgery or certain heart procedures in the past year.
- You cannot have an active infection, bleeding issues, or require a pacemaker.
- You must not have had a heart attack or stroke in the last month.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a catheter-based procedure can safely repair a leaking mitral heart valve in people who still have symptoms despite best medical treatment. If you qualify, it may improve symptoms and heart function without open-heart surgery.
This trial studies a new way to replace a damaged mitral heart valve using a catheter (a thin tube), instead of open-heart surgery. It may help people who have severe leaking of the mitral valve but are considered too high-risk for surgery.
This study tests a new type of prosthetic heart valve made from a special polymer material. It is for adults who need surgical replacement of either the mitral or aortic valve.
This trial tests a new type of artificial heart valve made of polymer (a special plastic-like material) for people with severe aortic valve disease. It aims to see if the valve is safe and works well, giving you an option for a replacement valve that might last longer.
This trial tests a new polymer heart valve for people with severe aortic valve narrowing or leakage. It aims to see if the valve is safe and works well as a replacement.
This trial tests a new device called the SATURN system, which places a new mitral valve without open-heart surgery. It is for people aged 65 and older with severe mitral regurgitation who are at high risk for surgery.
Hear when a new Severe Mitral Valve Regurgitation, Severe Mitral Valve Stenosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.